Status:
RECRUITING
The Effect of Supplementation With Fish Oil (EPAX EVOLVE 05) on Sperm Quality
Lead Sponsor:
Epax Norway AS
Conditions:
Infertility, Male
Eligibility:
MALE
18-55 years
Phase:
NA
Brief Summary
The study will enrol men that have a poor sperm quality. They will take either a placebo or fish oil capsule (2 per day) for 3 months. At the beginning and end of the study the participant will be ask...
Detailed Description
The study is a 2-armed, comparator controlled, double-blinded study. Subjects, study staff, sperm quality assessor and statistician will be blinded to the nutritional intervention. The study Sponsor ...
Eligibility Criteria
Inclusion
- Men aged 18-55
- Referred for or claiming a semen analysis.
- Willing to have at least 2 days abstinence of sexual activity prior to a sperm sample being taken.
- Reduced semen quality defined as:
- • Progressive motility: \<30%
- Willing to refrain from omega-3/cod liver oil supplementation during the study. Use of other supplements is allowed.
- \-
Exclusion
- Known allergy to fish products
- Historically, known, or suspected bacterial infection in reproductive organs
- Varicocele suspected from physical examination
- Azoospermia
- Diagnosis of diabetes (type 2)
- Diagnosis of Crohn´s Disease
- Inferior semen quality due to medical reasons, such as cryptorchidism (via questionnaire/medical records) -
Key Trial Info
Start Date :
March 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 20 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06950203
Start Date
March 10 2025
End Date
December 20 2026
Last Update
May 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medicus Group AS
Oslo, Norway, 0161